跳至主要内容
临床试验/JPRN-UMIN000019574
JPRN-UMIN000019574已完成未知

Effect of Denosumab and Alendronate on glucocorticoid-induced osteoporosis in patients with glomerulonephritis:a randomized controlled trial - Effect of Denosumab and Alendronate on glucocorticoid-induced osteoporosis in patients with glomerulonephritis:a randomized controlled trial

Showa University School of Medicine0 个研究点目标入组 30 人开始时间: 2015年10月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who are considered to be contraindicated for denosumab. 2) Patients who are considered to be contraindicated for alendronate. 3) Cancer patients. 4) Patients who have pretreated with bisphosphonate in recent 6 months. 5) Patients who have pretreated with denosumab in recent 6 months. 6) Patients whose eGFR is less than 35ml/min/1.73m2. 7) Patients whose i-PTH is more than 300ml/min. 8) Patients whose corrected Ca is less than 8.4 mg/dL. 9) Patients who are thought to be inappropriate for this study by physician.

研究者

发起方
Showa University School of Medicine

相似试验